Published in Cancer Res on August 01, 1998
Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell (2011) 4.41
Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol Cell Biol (2004) 3.96
Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J (2001) 3.21
Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci U S A (1999) 2.97
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77
Unraveling the mechanism of BRCA2 in homologous recombination. Nat Struct Mol Biol (2011) 1.59
Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat Med (2008) 1.47
Variants in the GH-IGF axis confer susceptibility to lung cancer. Genome Res (2006) 1.44
Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models. Mol Cancer Ther (2012) 1.00
Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes. Nature (2013) 0.99
The relative efficiency of homology-directed repair has distinct effects on proper anaphase chromosome separation. Nucleic Acids Res (2011) 0.97
FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex. Cell Cycle (2015) 0.95
Functional assays for analysis of variants of uncertain significance in BRCA2. Hum Mutat (2013) 0.92
EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases. Mol Genet Genomics (2011) 0.89
Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum Mol Genet (2012) 0.88
BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication. DNA Repair (Amst) (2015) 0.84
Chromosomal Rearrangements in Cancer: Detection and potential causal mechanisms. Mol Cell Oncol (2014) 0.83
Ku80-deleted cells are defective at base excision repair. Mutat Res (2013) 0.82
Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor. Nucleic Acids Res (2005) 0.82
Radiation enhances caspase 3 cleavage of Rad51 in BRCA2-defective cells. Radiat Res (2008) 0.81
Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks. Mutat Res (2014) 0.81
Trex2 enables spontaneous sister chromatid exchanges without facilitating DNA double-strand break repair. Genetics (2011) 0.79
PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells. PLoS One (2016) 0.79
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers. Can Urol Assoc J (2011) 0.78
Restoration of CAPAN-1 cells with functional BRCA2 provides insight into the DNA repair activity of individuals who are heterozygous for BRCA2 mutations. Cancer Genet Cytogenet (2008) 0.76
A mechanism for 1,4-Benzoquinone-induced genotoxicity. Oncotarget (2016) 0.75
Expression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue. PLoS One (2017) 0.75
Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability. PLoS One (2017) 0.75
Defining a genotoxic profile with mouse embryonic stem cells. Exp Biol Med (Maywood) (2013) 0.75
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (1997) 8.04
A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol Cell Biol (1996) 5.75
Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell (1996) 4.11
Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci U S A (1999) 2.97
Defective embryonic neurogenesis in Ku-deficient but not DNA-dependent protein kinase catalytic subunit-deficient mice. Proc Natl Acad Sci U S A (2000) 1.90
Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol Cell Biol (2000) 1.54
Maintenance of an extrachromosomal plasmid vector in mouse embryonic stem cells. Proc Natl Acad Sci U S A (1995) 1.36
Modifying the mouse: design and desire. Biotechnology (N Y) (1992) 1.36
Targeting frequency for deletion vectors in embryonic stem cells. Mol Cell Biol (1994) 1.29
A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum Mol Genet (1993) 1.22
Targeted mutation in beta1,4-galactosyltransferase leads to pituitary insufficiency and neonatal lethality. Dev Biol (1997) 1.14
Genetic manipulation of the mouse via gene targeting in embryonic stem cells. Ciba Found Symp (1992) 0.99
Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cells. Proc Natl Acad Sci U S A (1991) 0.98
Disruption of the G(i2) alpha locus in embryonic stem cells and mice: a modified hit and run strategy with detection by a PCR dependent on gap repair. Transgenic Res (1993) 0.95
Ku80 and p53 suppress medulloblastoma that arise independent of Rag-1-induced DSBs. Oncogene (2006) 0.94
Gene targeting in mouse embryonic stem cells with an adenoviral vector. Somat Cell Mol Genet (1995) 0.91
Deleting Ku70 is milder than deleting Ku80 in p53-mutant mice and cells. Oncogene (2009) 0.89
Temporal, spatial and tissue-specific expression of a myogenin-lacZ transgene targeted to the Hprt locus in mice. Biotechniques (1999) 0.85
A polyoma-based episomal vector efficiently expresses exogenous genes in mouse embryonic stem cells. Nucleic Acids Res (1996) 0.85
Defining functional domains of Ku80: DNA end binding and survival after radiation. Biochem Biophys Res Commun (1999) 0.82
Targeting of the Gi2 alpha gene in ES cells with replacement and insertion vectors. J Recept Res (1993) 0.79